Cycloleucine blocks NMDA responses in cultured hippocampal neurones under voltage clamp: antagonism at the strychnine-insensitive glycine receptor
- PMID: 2556198
- PMCID: PMC1854780
- DOI: 10.1111/j.1476-5381.1989.tb14632.x
Cycloleucine blocks NMDA responses in cultured hippocampal neurones under voltage clamp: antagonism at the strychnine-insensitive glycine receptor
Abstract
1. Radioligand binding studies have demonstrated that the neutral amino acid cycloleucine may act as a competitive antagonist at the glycine modulatory site on the N-methyl-D-aspartate (NMDA) receptor complex. In the present study, we examined the effects of cycloleucine on NMDA-evoked inward current responses in dissociated hippocampal neuronal cultures using the whole cell voltage-clamp technique. 2. In the presence of 1 microM glycine, cycloleucine caused a reversible, dose-dependent inhibition of NMDA responses with an IC50 of 24 microM. An increase in glycine to 100 microM resulted in a shift to the right of the cycloleucine concentration-effect curve (IC50, 1.4 mM). However, with cycloleucine concentrations less than or equal to 100 microM, a fraction of the block could not be overcome by glycine even at concentrations as high as 1 mM. 3. The cycloleucine block was unaffected by shifts in the holding potential (-60 to +60 mV), and there was no effect of cycloleucine on the reversal potential of the NMDA-evoked current. 4. Cycloleucine failed to effect kainic acid- and quisqualic acid-evoked currents at concentrations which inhibited NMDA responses. 5. We conclude that cycloleucine is a potent and selective antagonist of NMDA-receptor mediated responses. Although this effect occurs in part via competitive antagonism at the glycine modulatory site, the cycloleucine block cannot be completely reversed by glycine indicating an interaction with an additional site on the receptor-channel complex.
Similar articles
-
L-proline activates glutamate and glycine receptors in cultured rat dorsal horn neurons.Mol Pharmacol. 1992 Apr;41(4):793-801. Mol Pharmacol. 1992. PMID: 1349155
-
Interaction of 6-cyano-7-nitroquinoxaline-2,3-dione with the N-methyl-D-aspartate receptor-associated glycine binding site.Mol Pharmacol. 1989 May;35(5):565-70. Mol Pharmacol. 1989. PMID: 2566902
-
Sites of antagonist action on N-methyl-D-aspartic acid receptors studied using fluctuation analysis and a rapid perfusion technique.J Neurophysiol. 1988 Aug;60(2):645-63. doi: 10.1152/jn.1988.60.2.645. J Neurophysiol. 1988. PMID: 2902200
-
Cycloleucine competitively antagonizes the strychnine-insensitive glycine receptor.Eur J Pharmacol. 1988 Jun 22;151(1):165-6. doi: 10.1016/0014-2999(88)90713-3. Eur J Pharmacol. 1988. PMID: 2843389 No abstract available.
-
Selective reduction of N-methyl-D-aspartate-evoked responses by 1,3-di(2-tolyl)guanidine in mouse and rat cultured hippocampal pyramidal neurones.Br J Pharmacol. 1993 Aug;109(4):1196-205. doi: 10.1111/j.1476-5381.1993.tb13749.x. Br J Pharmacol. 1993. PMID: 8401930 Free PMC article.
Cited by
-
PREDICT: a method for inferring novel drug indications with application to personalized medicine.Mol Syst Biol. 2011 Jun 7;7:496. doi: 10.1038/msb.2011.26. Mol Syst Biol. 2011. PMID: 21654673 Free PMC article.
-
Discovery and Characterization of Pyridoxal 5'-Phosphate-Dependent Cycloleucine Synthases.J Am Chem Soc. 2024 May 29;146(21):14672-14684. doi: 10.1021/jacs.4c02142. Epub 2024 May 14. J Am Chem Soc. 2024. PMID: 38743881 Free PMC article.
-
Design, Synthesis, and Biological Activity of Novel Ferulic Amide Ac5c Derivatives.ACS Omega. 2021 Oct 8;6(41):27561-27567. doi: 10.1021/acsomega.1c04644. eCollection 2021 Oct 19. ACS Omega. 2021. PMID: 34693177 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources